CoverageForm 410-K10-Q8-K13D13G13F

ACLS · Axcelis Technologies Inc - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · ACLS

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Revenue$198.96M-$213.61M$194.54M$192.56M-$256.56M$256.51M$252.37M-
Cost of Revenue$118.38M-$124.81M$107.20M$103.80M-$146.59M$144.10M$136.32M-
Gross Profit$80.58M-$88.81M$87.34M$88.77M-$109.97M$112.41M$116.05M-
R&D$28.52M-$24.64M$27.06M$27.13M-$26.39M$25.79M$25.66M-
SG&A$26.76M-$23.31M$16.31M$17.36M-$19.85M$16.58M$16.41M-
Total Operating Expenses$72.63M-$63.79M$58.38M$59.61M-$63.06M$59.60M$59.51M-
D&A$4.44M-$3.90M$3.90M$4.31M---$3.77M-
Operating Income$7.95M-$25.02M$28.96M$29.16M-$46.91M$52.81M$56.54M-
Interest Expense$1.29M-$1.30M$1.35M$1.35M-$1.33M$1.35M$1.35M-
Income Tax$1.41M-$4.16M$3.62M$4.50M-$6.79M$6.40M$7.40M-
Net Income$9.21M-$48.58M$50.87M$28.58M-$48.58M$50.87M$51.59M-
EPS - Basic$0.30-$0.83$0.99$0.89-$1.49$1.56$1.58-
EPS - Diluted$0.30-$0.83$0.98$0.88-$1.49$1.55$1.57-

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Cash & Equivalents$150.83M$145.45M$187.50M$173.65M$183.96M$123.51M$120.07M$145.17M$133.96M$167.30M
Accounts Receivable$161.81M$168.48M$147.64M$138.84M$164.95M$203.15M$183.54M$188.08M$208.54M$217.96M
Inventory$326.05M$329.01M$324.34M$310.77M$295.85M$282.23M$290.95M$283.09M$312.17M$306.48M
Accounts Payable$51.56M$42.31M$52.47M$37.11M$38.98M$46.93M$54.05M$45.78M$39.85M$54.40M
Current Assets$935.68M$943.20M$984.03M$1.06B$1.11B$1.12B$1.12B$1.08B$1.11B$1.08B
Total Assets$1.37B$1.36B$1.35B$1.32B$1.34B$1.35B$1.34B$1.29B$1.31B$1.28B
Current Liabilities$203.91M$197.66M$198.99M$177.11M$200.37M$207.52M$252.26M$244.18M$276.57M$285.13M
Long-term Debt----------
Total Liabilities$329.90M$326.67M$331.80M$301.10M$313.38M$335.99M$362.53M$353.46M$404.88M$417.08M
Stockholders' Equity$1.04B$1.03B$1.02B$1.02B$1.03B$1.01B$975.59M$934.95M$901.74M$864.88M
Retained Earnings$512.75M$503.54M$488.77M$487.16M$485.67M$470.32M$432.43M$396.72M$358.30M$319.51M

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Operating Cash Flow$18.14M---$39.80M---$42.22M-
Investing Cash Flow($10.64M)---$40.47M---($55.69M)-
Financing Cash Flow($1.40M)---($20.11M)---($18.05M)-
CapEx$1.84M---$4.96M---$1.62M-
Free Cash Flow$16.30M---$34.84M---$40.60M-

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Profitability
Gross margin40.5%-41.6%44.9%46.1%-42.9%43.8%46.0%-
Operating margin4.0%-11.7%14.9%15.1%-18.3%20.6%22.4%-
EBITDA margin6.2%-13.5%16.9%17.4%---23.9%-
Net margin4.6%-22.7%26.1%14.8%-18.9%19.8%20.4%-
Free cash flow margin8.2%---18.1%---16.1%-
FCF / Net income1.77---1.22---0.79-
R&D / Revenue14.3%-11.5%13.9%14.1%-10.3%10.1%10.2%-
SG&A / Revenue13.5%-10.9%8.4%9.0%-7.7%6.5%6.5%-
Effective tax rate13.3%-7.9%6.6%13.6%-12.3%11.2%12.5%-
Return on assets0.7%-3.6%3.8%2.1%-3.6%3.9%3.9%-
Return on equity0.9%-4.8%5.0%2.8%-5.0%5.4%5.7%-
Return on invested capital----------
Liquidity
Current ratio4.594.774.956.015.565.414.454.424.003.79
Quick ratio2.993.113.324.264.084.053.293.262.872.71
Cash ratio0.740.740.940.980.920.600.480.590.480.59
Leverage
Debt / Equity----------
Debt / Assets----------
Debt / EBITDA----------
Interest coverage6.2x-19.2x21.4x21.7x-35.2x39.1x42.0x-
Equity multiplier1.321.321.331.291.311.331.371.381.451.48
Liabilities / Assets0.240.240.250.230.230.250.270.270.310.33
Efficiency
Asset turnover0.14-0.160.150.14-0.190.200.19-
Inventory turnover0.36-0.380.340.35-0.500.510.44-
Days sales outstanding297d-252d260d313d-261d268d302d-
Days inventory outstanding1005d-949d1058d1040d-724d717d836d-
Days payable outstanding159d-153d126d137d-135d116d107d-
Cash conversion cycle1143d-1047d1192d1216d-851d869d1031d-
Valuation
P / E310.3x-117.6x71.1x56.4x-70.4x91.7x71.0x-
P / B2.8x-3.0x2.2x1.6x-3.5x5.0x4.1x-
P / S14.5x-14.4x11.4x8.3x-13.4x18.2x14.5x-
EV / EBITDA220.6x-99.7x62.3x42.5x---58.7x-
Growth
Revenue growth (YoY)3.3%--16.7%-24.2%-23.7%--12.2%-6.4%-0.6%-
Revenue CAGR (3y)-7.8%--2.3%-4.2%-1.8%-13.2%20.3%23.9%-
Revenue CAGR (5y)8.4%-14.1%9.6%10.1%-29.9%28.1%22.5%-
Gross profit growth (YoY)-9.2%--19.2%-22.3%-23.5%--15.2%-6.1%11.6%-
Operating income growth (YoY)-72.7%--46.7%-45.2%-48.4%--34.6%-17.1%10.1%-
Net income growth (YoY)-67.8%-0.0%0.0%-44.6%--26.3%-17.4%8.2%-
EPS growth (YoY)-65.9%--44.3%-36.8%-43.9%--25.1%-16.7%9.8%-
EPS CAGR (3y)-40.6%--11.8%-9.5%-10.3%-22.5%41.3%48.4%-
EPS CAGR (5y)-9.0%-21.0%20.2%21.7%-136.8%138.7%54.2%-
FCF growth (YoY)-53.2%----14.2%---25.6%-
FCF CAGR (5y)3.5%----1.9%-----
Book value growth (YoY)1.7%2.2%4.6%9.4%13.9%17.1%21.8%25.7%28.5%29.6%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$839.05M total
Single Reportable Segment$839.05M · 100.0%

Product / service

$2.52B total
Ion Implantation Systems Services And Royalties$824.10M · 32.7%
Product$792.04M · 31.5%
New Systems Revenue$571.02M · 22.7%
After Market$268.03M · 10.6%
Services$47.00M · 1.9%
Other Products Systems Services And Royalties$14.95M · 0.6%

Geographic

$1.68B total
Non Us$702.00M · 41.8%
US$482.64M · 28.8%
Asia Pacific$306.45M · 18.3%
North America$137.08M · 8.2%
Europe$49.95M · 3.0%

Peer comparison

Same SIC group: Special Industry Machinery, NEC

CompanyRevenue (last FY)Net marginROE
VLD$45.97M-155.2%-187.0%
DM---
CRCT$708.78M10.8%22.3%
LRCX$18.44B29.1%54.3%
VECO--4.0%

Comparing AXCELIS TECHNOLOGIES INC against the 5 most active filers in the same SIC group.